Ling Zeng serves as Executive at Dicerna Pharmaceuticals Inc, where they oversee executive responsibilities. Since joining the company, Ling Zeng has executed 5 insider transactions totaling $28.6K, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 28, 2021 involved transacting 5,032 shares valued at $192.5K.
Ling Zeng currently holds 5,784 shares of Dicerna Pharmaceuticals Inc (DRNA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ling Zeng has been a net seller of DRNA stock. They have purchased $0 and sold $28.6K worth of shares.
Ling Zeng's most recent insider trade was on Dec 28, 2021, when they sold 5,032 shares at $38.25 per share.
Get notified when new Form 4 filings are submitted
| 2,562 |
| $N/A |
| Discretionary |
| Dec 15, 2021 | DRNA | $28.6K | Payment | 752 | $38.05 | Discretionary |
| Sep 17, 2021 | DRNA | $28.6K | Sale | 1,334 | $21.47 | Discretionary |
| Sep 15, 2021 | DRNA | $0 | Option Exercise | 4,556 | $N/A | Discretionary |